Patents by Inventor Andreas Raab

Andreas Raab has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150024009
    Abstract: The invention provides an isolated genetically modified non-mammalian organism, wherein the activity of acyl-CoA:sterol acyltransferase/sterol O-acyltransferase (EC 2.3.1.26) and/or diacylglycerol acyltransferase/diacylglycerol O-acyltranferase (EC 2.3.1.20) and/or lecithin cholesterol acyl transferase/phospholipid: diacylglycerol acyltransferase (EC 2.3.1.158) and/or acyl CoA-wax alcohol acyltransferase (EC 2.3.1.75) is reduced or abolished in comparison with a corresponding wildtype organism, methods of use of such an organism, shuttle vehicles for making such an organism and methods for producing such an organism.
    Type: Application
    Filed: September 19, 2014
    Publication date: January 22, 2015
    Applicant: ORGANOBALANCE GMBH
    Inventors: Christine Lang, Andreas Raab
  • Patent number: 8841114
    Abstract: The invention provides an isolated genetically modified non-mammalian organism, wherein the activity of acyl-CoA: sterol acyltransferase/sterol O-acyltransferase (EC 2.3.1.26) and/or diacylglycerol acyltransferase/diacylglycerol O-acyltranferase (EC 2.3.1.20) and/or lecithin cholesterol acyl transferase/phospholipid: diacylglycerol acyltransferase (EC 2.3.1.158) and/or acyl CoA-wax alcohol acyltransferase (EC 2.3.1.75) is reduced or abolished in comparison with a corresponding wildtype organism, methods of use of such an organism, shuttle vehicles for making such an organism and methods for producing such an organism.
    Type: Grant
    Filed: August 4, 2010
    Date of Patent: September 23, 2014
    Assignee: OrganoBalance GmbH
    Inventors: Christine Lang, Andreas Raab
  • Publication number: 20140186409
    Abstract: The invention relates to a microorganism, of the order of lactic acid bacteria or analog, fragment, derivative, mutant or combination thereof. Said microorganism, or analog, fragment, derivative, mutants or combinations thereof can be co-aggregated with at least Staphylococcus aureus or Pseudomonas aeruginosa.
    Type: Application
    Filed: May 7, 2012
    Publication date: July 3, 2014
    Applicant: ORGANOBALANCE MEDICAL AG
    Inventors: Christine Lang, Andreas Raab, Patrick Golletz
  • Publication number: 20140144264
    Abstract: In a device for releasing a securing screw for a unit in a housing, in particular a pinion unit in a steering gear of a motor vehicle, the securing screw is connected via an external thread to an internal thread in the housing, wherein the securing screw is provided with a latching device, which has latching levers disposed distributed on the circumference of the securing screw, each of which said latching levers is provided with latching lugs disposed on the free ends of the latching levers. The latching lugs latch into toothing gaps of a toothing geometry of the housing. The latching device can be connected to a tool in order to release the latching levers having the latching lugs from the latched position by means of a radially inwardly directed movement of the latching levers.
    Type: Application
    Filed: July 11, 2012
    Publication date: May 29, 2014
    Applicant: ZF LENKSYSTEME GMBH
    Inventors: Andreas Raab, Andreas Stahl
  • Patent number: 8685704
    Abstract: The invention relates to an isolated genetically modified microorganism in which the gene IDH1 and at least one of the genes SDH2 and DIC1 are under the control of a first promoter that is repressed to a growth culture medium by means of a cultivation additive and is active in the absence of the cultivation additive. The genes that are part of the group comprising “PYC1, ACS1, CIT1, ACO1, ICL1, MSL1, and CIT2, optionally also MDH3” are constitutively active. The invention further relates to uses of such a microorganism, especially for producing succinic acid.
    Type: Grant
    Filed: April 16, 2008
    Date of Patent: April 1, 2014
    Assignee: Organo-Balance GmbH
    Inventors: Christine Lang, Markus Veen, Mewes Bottner, Andreas Raab
  • Publication number: 20140065218
    Abstract: The invention describes a microorganism of the order of lactic acid bacteria or an analogue, fragment, derivative, mutant or combination thereof, wherein the microorganism, or analogue, fragment, derivative, mutant or combination thereof can coaggregate with Streptococcus pyogenes.
    Type: Application
    Filed: May 16, 2012
    Publication date: March 6, 2014
    Applicant: ORGANOBALANCE MEDICAL AG
    Inventors: Christine Lang, Andreas Raab, Natalia Bolotina
  • Publication number: 20140057328
    Abstract: The present invention relates to a yeast cell, wherein said cell comprises a functional gene coding for soluble hydroxymethylglutaryl-coenzyme-A (HMG-CoA) reductase; one or more gene(s) coding for steryl acyltransferase(s) in said cell are defective or deleted; and said cell is prototrophic for at least histidine, leucine or uracil. Moreover, the present invention relates to the use of said cell for the production of one or more terpene(s). Further, the present invention relates to methods of generating said cell and the production of one or more terperne(s) and a pharmaceutical or cosmetically composition, a lubricant or transformer oil comprising said terpene(s).
    Type: Application
    Filed: February 15, 2012
    Publication date: February 27, 2014
    Inventors: Andreas Raab, Christine Lang
  • Publication number: 20120156695
    Abstract: The invention relates to an isolated, genetically modified, living non-mammal organism, having increased HMG-CoA-reductase activity compared to the wild type, and having reduced C24-methyltransferase and/or delta22-desaturase activity compared to the wild type. The invention is characterized in that the organism has increased dehydrocholesterol-delta70-reductase activity compared to the wild type. The invention further relates to different uses of such an organism, to a test kit comprising such an organism, and to a membrane extract of such an organism.
    Type: Application
    Filed: April 1, 2010
    Publication date: June 21, 2012
    Applicant: ORGANOBALANCE GMBH
    Inventors: Michael Schilling, Christine Lang, Andreas Raab
  • Publication number: 20120156249
    Abstract: The invention provides an isolated genetically modified non-mammalian organism, wherein the activity of acyl-CoA: sterol acyltransferase/sterol O-acyltransferase (EC 2.3.1.26) and/or diacylglycerol acyltransferase/diacylglycerol O-acyltranferase (EC 2.3.1.20) and/or lecithin cholesterol acyl transferase/phospholipid: diacylglycerol acyltransferase (EC 2.3.1.158) and/or acyl CoA-wax alcohol acyltransferase (EC 2.3.1.75) is reduced or abolished in comparison with a corresponding wildtype organism, methods of use of such an organism, shuttle vehicles for making such an organism and methods for producing such an organism.
    Type: Application
    Filed: August 4, 2010
    Publication date: June 21, 2012
    Applicant: ORGANOBALANCE GMBH
    Inventors: Christine Lang, Andreas Raab
  • Publication number: 20120064988
    Abstract: A golf putter head a putter head body. The letterhead body has a putter base, a putter top, a putter striking face, and a putter rear wall. A hosel connection is mounted on the putter head. An opening is sized to receive a standard regulation golf ball and a rim formed at the entrance of the opening. An inside surface of an opening wall provides a tee hole having a substantially horizontal direction and is sized to receive a standard tee. The tee hole communicates with the opening. The tee hole is positioned to allow ejecting of a golf ball within the opening, when the tee is pressed into the tee hole.
    Type: Application
    Filed: November 8, 2010
    Publication date: March 15, 2012
    Inventor: Andreas Raab
  • Publication number: 20110300595
    Abstract: The invention relates to an isolated, genetically modified microorganism, wherein compared to the wild type a) the idh1 and idp1 genes have been deleted or inactivated, and/or b) the sdh2 and sdh1 genes have been deleted or inactivated, and/or c) the PDC2 gene has been deleted or inactivated or is under the control of a promoter which can be suppressed or induced by exposure of the microorganism using an inductor substance, and/or d) one or more genes from the group consisting of ICL1, MLS1, ACS1 and MDH3 has been replaced or supplemented by a corresponding foreign gene or corresponding foreign genes from Crabtree-negative organisms, and to the uses thereof.
    Type: Application
    Filed: October 7, 2009
    Publication date: December 8, 2011
    Applicant: ORGANO BALANCE GMBH
    Inventors: Christine Lang, Andreas Raab
  • Publication number: 20110129885
    Abstract: The invention relates to an isolated genetically modified microorganism in which the gene IDH1 and at least one of the genes SDH2 and DIC1 are under the control of a first promoter that is repressed to a growth culture medium by means of a cultivation additive and is active in the absence of the cultivation additive. The genes that are part of the group comprising “PYC1, ACS1, CIT1, ACO1, ICL1, MSL1, and CIT2, optionally also MDH3” are constitutively active. The invention further relates to uses of such a microorganism, especially for producing succinic acid.
    Type: Application
    Filed: April 16, 2008
    Publication date: June 2, 2011
    Applicant: ORGANO-BALANCE GMBH
    Inventors: Christine Lang, Markus Veen, Mewes Böttner, Andreas Raab
  • Patent number: D638890
    Type: Grant
    Filed: September 13, 2010
    Date of Patent: May 31, 2011
    Inventor: Andreas Raab